Riskpilot← Back to searchSign inGet full accessRECENS INVEST AS
ASActiveOrg 916162421Marmorneset 21, 5232 ParadisMedical specialists activities · NACE 8622Est. 20151 employees
Revenue 2021
NOK 3,6M
+36% vs 2020
EBITDA margin
6.0%
+128% vs 2020
Equity ratio
51.3%
Financial strength
Net profit 2021
NOK 3,8M
+542% vs 2020
| Revenue | NOK 3,6M | +36% |
| EBITDA | NOK 216K | +128% |
| Net profit | NOK 3,8M | +542% |
| Total assets | NOK 5,8M | +89% |
| Equity | NOK 3M | +450% |
| Employees | 1 | — |
Legal name
RECENS INVEST AS
Org number
916162421
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
31. oktober 2015
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Erverv av eierandeler i bedrifter og andre eiendeler, samt annet som naturlig er knyttet til dette. Selskapet skal drive med formidling/salg av helsetjenester.
Address
Marmorneset 21, 5232 Paradis
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1 656 | 4 868 | 2 746 | 2 640 | 3 593 |
| Staff expenses | −0 | −48 | −43 | −15 | −32 |
| EBITDA | 453 | 1 706 | −242 | −768 | 216 |
| Depreciation & amort. | −17 | −64 | −2 | −36 | −34 |
| EBIT | 435 | 1 643 | −244 | −804 | 183 |
| Net financials | 221 | −472 | −48 | −57 | 3 622 |
| Profit before tax | 657 | 1 171 | −292 | −861 | 3 804 |
| Tax | 103 | 383 | −7 | −0 | −0 |
| Net profit | 553 | 788 | −285 | −861 | 3 804 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 3 513 | 2 615 | 3 312 | 3 048 | 5 774 |
| Equity | 713 | 301 | 17 | −844 | 2 960 |
| Long-term debt | 18 | 7 | 3 202 | 3 449 | 653 |
| Short-term debt | 2 781 | 2 306 | 94 | 443 | 2 162 |
| Total debt | 2 799 | 2 313 | 3 295 | 3 893 | 2 814 |
EBITDA margin
6.0%
This company
15.8%
Market median
-62% vs market
20172021
Equity ratio
51.3%
This company
38.2%
Market median
+34% vs market
20172021
Return on equity
128.5%
This company
18.4%
Market median
+598% vs market
20172021
Net profit margin
105.9%
This company
8.1%
Market median
+1207% vs market
20172021
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20172021
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AI Chief Executive Officer | Chief Executive Officer | 2015 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RECENS INVEST AS (this company)
Norsk Treningshelse AsBoard members of RECENS INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Instebø | Chief Executive Officer | 0 companies |